Status:

COMPLETED

Impact of a Corrie Cardiac Rehabilitation Program

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

American Heart Association

Apple Inc.

Conditions:

Coronary Artery Disease

Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • 18 years or older
  • Individuals admitted to the hospital for the following conditions or interventions during the index admission: Acute myocardial infarction (STEMI or NSTEMI type 1), Coronary artery bypass grafting (CABG), and Coronary artery angioplasty/stenting (PCI), Heart valve surgery, catheter-based aortic valve replacement (TAVR).
  • Exclusion Criteria
  • Non-English speaking
  • Symptomatic severe aortic stenosis or other severe valvular disease
  • Physical disability that would preclude safe and adequate exercise performance
  • Hypertrophic obstructive cardiomyopathy with peak resting left ventricular outflow gradient of \>25 mmHg
  • Known aortic dissection
  • Severe resting arterial hypertension (Systolic blood pressure \>200 mmHg or diastolic BP \>110mmHg) at baseline assessment
  • Mental impairment leading to inability to cooperate with study procedures
  • Untreated high degree atrioventricular block
  • Atrial fibrillation with uncontrolled ventricular rate (Heart rate \>110 at rest) at baseline assessment
  • History of cardiac arrest or sudden death
  • Myocardial infarction or cardiac surgery complications with cardiogenic shock and/or congestive heart failure and/or signs/symptoms of post-procedure ischemia
  • Left ventricular ejection fraction \<40%
  • History of Clinically significant depression
  • Visual or hearing impairment which precludes the use of the intervention
  • Presence of cardiac defibrillator
  • Incomplete revascularization procedure
  • History of one or more episodes of falls in the last year
  • Pregnancy
  • If patients are deemed clinically unstable and unable to participate at the time of initial screening, the research team member may return at a later date to determine whether this status has changed.

Exclusion

    Key Trial Info

    Start Date :

    April 3 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 14 2024

    Estimated Enrollment :

    259 Patients enrolled

    Trial Details

    Trial ID

    NCT05238103

    Start Date

    April 3 2023

    End Date

    October 14 2024

    Last Update

    December 5 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Johns Hopkins University

    Baltimore, Maryland, United States, 21287